Bio-Works Technologies AB (publ) Stock Nasdaq Stockholm
Equities
SE0007387089
Medical Equipment, Supplies & Distribution
Sales 2021 | 56.36M 5.19M | Sales 2022 | 41.32M 3.81M | Capitalization | 736M 67.86M |
---|---|---|---|---|---|
Net income 2021 | -12M -1.11M | Net income 2022 | -45M -4.15M | EV / Sales 2021 | 15.2 x |
Net cash position 2021 | 103M 9.47M | Net cash position 2022 | 65.88M 6.07M | EV / Sales 2022 | 16.2 x |
P/E ratio 2021 |
-66.3
x | P/E ratio 2022 |
-16.4
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 56.22% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Royce
CEO | Chief Executive Officer | 47 | 20-06-25 |
Founder | - | 05-12-31 | |
Arne Hauge
DFI | Director of Finance/CFO | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 71 | 13-09-23 | |
Johan Sedihn
BRD | Director/Board Member | 59 | 20-05-14 |
Peter Nählstedt
BRD | Director/Board Member | 50 | 20-05-14 |
1st Jan change | Capi. | |
---|---|---|
-2.89% | 185B | |
-2.43% | 107B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+3.86% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.40% | 25.66B |